Neurona Therapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 57
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $41.5M
Latest Deal Amount
  • Investors
  • 8

Neurona Therapeutics General Information

Description

Developer of cell-based therapies designed to treat intractable neurological disease. The company's therapies generate specific types of nerve cells for targeted delivery into the injured nervous system, enabling physicians to accelerate their treatments for patients with significant unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 170 Harbor Way
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Neurona Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurona Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 22-Jun-2021 $41.5M 000.00 Completed Pre-Clinical Trials
6. Debt - PPP 30-Apr-2020 00000 000.00 Completed Pre-Clinical Trials
5. Later Stage VC (Series C) 25-Nov-2019 0000 000.00 00000 Completed Pre-Clinical Trials
4. Grant 31-Oct-2019 00.000 000.00 Completed Pre-Clinical Trials
3. Later Stage VC (Series B) 26-Feb-2018 0000 000.00 0000 Completed Pre-Clinical Trials
2. Later Stage VC (Series A) 28-Dec-2016 $28.7M $28.8M 000.00 Completed Pre-Clinical Trials
1. Early Stage VC 14-Aug-2008 $95K $95K Completed Startup
To view Neurona Therapeutics’s complete valuation and funding history, request access »

Neurona Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 16,703,606 $0.000100 $0.1 $1.2 $1.2 1x $1.2 15.96%
Series A 31,867,492 $0.000100 $0.07 $0.9 $0.9 1x $0.9 30.46%
To view Neurona Therapeutics’s complete cap table history, request access »

Neurona Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cell-based therapies designed to treat intractable neurological disease. The company's therapies generate s
Drug Discovery
South San Francisco, CA
57 As of 2021
000.00
00000000000 000.00

00000 00

tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad m
0000 000000000
Cambridge, MA
00000
0000 0000-00-00
000000&0 00000

0000000

e irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
0000 000000000
San Carlos, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurona Therapeutics Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Semma Therapeutics Formerly VC-backed Cambridge, MA 00000 000000&0 00000
0000000 Venture Capital-Backed San Carlos, CA 00 000.00 00000000000 000.00
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
0000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000000 Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Neurona Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Cory Nicholas Ph.D Co-Founder, Chief Executive Officer & Board Member
Celinda Moore Director & Head of People
James Tanaka Director of Finance
Arturo Álvarez-Buylla Ph.D Co-Founder & Scientific Advisor
John Rubenstein Ph.D Co-Founder & Scientific Advisor
You’re viewing 5 of 9 executive team members. Get the full list »

Neurona Therapeutics Board Members (8)

Name Representing Role Since
Arnold Kriegstein Neurona Therapeutics Co-Founder, Board Member & Scientific Advisor 000 0000
Cory Nicholas Ph.D Neurona Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
David Goeddel Ph.D The Column Group Board Member 000 0000
Erica Whittaker Ph.D Self Board Member 000 0000
Leo Guthart Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Neurona Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurona Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Euclidean Capital Other Minority 000 0000 000000 0
Ironfire Ventures Venture Capital Minority 000 0000 000000 0
Sphera Funds Management Hedge Fund Minority 000 0000 000000 0
UCB Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »